BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3296437)

  • 1. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cells and tumor immunity: 1987.
    Hiserodt JC; Herberman RB
    Year Immunol; 1989; 4():201-7. PubMed ID: 2648702
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrasuppression, tolerance, and tumor immunity.
    Green DR; Friedman A; Ptak W; McGhee J; Flood PM
    Prog Clin Biol Res; 1989; 288():245-58. PubMed ID: 2566175
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological properties of tumor cells that determine the degree of their malignancy].
    LavrovskiÄ­ VA; Viksler VKh
    Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110
    [No Abstract]   [Full Text] [Related]  

  • 5. NKT cells and tumor immunity--a double-edged sword.
    Smyth MJ; Godfrey DI
    Nat Immunol; 2000 Dec; 1(6):459-60. PubMed ID: 11101862
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.
    Topalian SL; Rosenberg SA
    Important Adv Oncol; 1990; ():19-41. PubMed ID: 2182519
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
    Talmadge JE; Herberman RB
    Cancer Treat Rep; 1986 Jan; 70(1):171-82. PubMed ID: 3510733
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoregulatory T cells in tumor immunity.
    Terabe M; Berzofsky JA
    Curr Opin Immunol; 2004 Apr; 16(2):157-62. PubMed ID: 15023407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology. Stress, NK receptors, and immune surveillance.
    Pardoll DM
    Science; 2001 Oct; 294(5542):534-6. PubMed ID: 11567108
    [No Abstract]   [Full Text] [Related]  

  • 11. Innate immune recognition and suppression of tumors.
    Hayakawa Y; Smyth MJ
    Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses and perspectives in cancer immunotherapy.
    Nguyen van Binh P; Duc HT
    Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells and their possible roles in host resistance against tumors.
    Herberman RB
    Transplant Proc; 1984 Apr; 16(2):476-8. PubMed ID: 6719548
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic aspects of malignant tumors.
    Ariyan S
    Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
    [No Abstract]   [Full Text] [Related]  

  • 15. Functions of natural killer cells.
    Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological abnormality in malignant neoplasms].
    Tsubura E; Yamashita Y; Yagi M
    Nihon Rinsho; 1981 Apr; 39(4):1772-7. PubMed ID: 6458709
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protein deficiency, host defense and natural anti-tumor immunity].
    Ruffmann R; Schlick E; Tartaris T; Chirigos MA
    Infusionsther Klin Ernahr; 1986 Apr; 13(2):106-12. PubMed ID: 3519454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
    Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.